Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| China Health Industries Holdings Inc (QB) | CHHE | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.9899 | 16:01:19 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.9899 | 0.9899 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.10 - 4.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.9899 | USD |
China Health Industries Holdings Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 64.88M | 65.54M | 8.65M | 112k | -408k | -0.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
China Health Industries (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHHE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.956 | 2.96 | 0.52 | 1.43 | 5,439 | 0.0339 | 3.55% |
| 3 Months | 0.2924 | 2.96 | 0.1676 | 0.9259956 | 6,115 | 0.6975 | 238.54% |
| 6 Months | 0.58 | 2.96 | 0.1676 | 0.8983759 | 4,333 | 0.4099 | 70.67% |
| 1 Year | 0.149 | 4.15 | 0.10 | 1.49 | 6,391 | 0.8409 | 564.36% |
| 3 Years | 0.2027 | 4.15 | 0.0107 | 1.24 | 4,149 | 0.7872 | 388.36% |
| 5 Years | 0.75 | 4.15 | 0.0107 | 1.04 | 3,273 | 0.2399 | 31.99% |
China Health Industries (QB) Description
| The Company, through different subsidiaries, has the capacity to produce 21 different NMPA-approved medicines, 14 NMPA-approved health supplement products and 8 hemp derivative products. In addition, the Company, through its wholly owned subsidiaries, holds one patent for utility models, five patents for external design, and three trademarks in China. The Company is licensed to sell its products, including its medical drugs, only in the PRC. The Company has newly developed certain products that are derived from hemp. It began to sell its new products since May 2018. Hemp Oil, Hemp Protein Powder, Hemp Polypeptide and Collagen Peptide are sold through Humankind. Other cosmetics are sold through HLJ Huimeijia. |
